IL6 and cancer: In addition, other authors have reported better prognosis in CC homozygous patients of IL-6 promoter polymorphism (-174 G/C) in various diseases, such us different types of cancer, surgical coronary revascularization and end-stage renal disease on hemodialysis [10,11,12,13,14].